Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease
Clinical trial NCT04294641 · COMPLETED
Trial details
- NCT number
- NCT04294641
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-10
- Primary completion
- 2024-06-24
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.